NK cell immunotherapies
Nov 22, 2024
The Promise of NK Cells: A Novel Approach to Immunotherapy
NK cell therapies have demonstrated significant clinical efficacy, with studies reporting response rates ranging from 40% to 80% in certain hematologic malignancies. As of recent data, several NK cell therapy candidates are in clinical trials, with notable successes including improved overall survival rates and red...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
